{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:13:39Z","timestamp":1772662419297,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T19:09:42Z","timestamp":1564081782000},"page":"783-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent Advances in Cutaneous T-cell Lymphoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Margaret","family":"Cocks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Wick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2019.03.006_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2018.00198","article-title":"New therapies and immunological findings in cutaneous T-cell lymphoma","volume":"8","author":"Fujii","year":"2018","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/modpathol.2009.175","article-title":"Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging","volume":"23","author":"Feng","year":"2010","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-Vbeta chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2019.03.006_bib5","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"issue":"308","key":"10.1016\/j.path.2019.03.006_bib6","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2015.04.030","article-title":"T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides","volume":"73","author":"Sufficool","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"issue":"32","key":"10.1016\/j.path.2019.03.006_bib11","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaad.2013.09.007","article-title":"Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US cutaneous lymphoma consortium","volume":"70","author":"Kadin","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cll.2017.06.006","article-title":"Cutaneous T-cell lymphoma","volume":"37","author":"Pulitzer","year":"2017","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.path.2019.03.006_bib14","article-title":"The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients","author":"Scarisbrick","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaad.2016.03.009","article-title":"New insights into folliculotropic mycosis fungoides (FMF): a single-center experience","volume":"75","author":"Hodak","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000484203","article-title":"Folliculotropism does not affect overall survival in mycosis fungoides: results from a single-center cohort and meta-analysis","volume":"233","author":"Giberson","year":"2017","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.path.2019.03.006_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000478-199407000-00001","article-title":"The histologic spectrum of mycosis fungoides\/S\u00e9zary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes","volume":"18","author":"Shapiro","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.03.006_bib20","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000679","article-title":"Interstitial mycosis fungoides: a clinicopathologic study of 21 patients","volume":"40","author":"Reggiani","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"Supplement_4","key":"10.1016\/j.path.2019.03.006_bib21","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol"},{"issue":"32","key":"10.1016\/j.path.2019.03.006_bib22","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"10.1016\/j.path.2019.03.006_bib23","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2014.60.3969","article-title":"Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sezary syndrome with variable CD30 expression level: a multi-institution collaborative project","volume":"33","author":"Kim","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10094","key":"10.1016\/j.path.2019.03.006_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jid.2017.11.035","article-title":"Variability in the expression of immunohistochemical markers: implications for biomarker interpretation in cutaneous T-cell lymphoma","volume":"138","author":"Rahbar","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/PAS.0000000000001041","article-title":"The use of central pathology review with digital slide scanning in advanced-stage mycosis fungoides and Sezary syndrome: a multi-institutional and international pathology study","volume":"42","author":"Gru","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib27","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jaad.2011.06.014","article-title":"Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sezary syndrome","volume":"66","author":"Nagler","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.path.2019.03.006_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0190-9622(96)90605-2","article-title":"Detection of circulating T cells with CD4+CD7\u2212 immunophenotype in patients with benign and malignant lymphoproliferative dermatoses","volume":"35","author":"Harmon","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/jid.2014.356","article-title":"CD158k is a reliable marker for diagnosis of Sezary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells","volume":"135","author":"Moins-Teisserenc","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cyto.b.20395","article-title":"CD158k\/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry","volume":"74","author":"Bahler","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.jid.5701013","article-title":"CD158K\/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of S\u00e9zary syndrome","volume":"128","author":"Ortonne","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.path.2019.03.006_bib35","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-16-3185","article-title":"Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with Sezary syndrome","volume":"23","author":"Hurabielle","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1309\/3A32DTVMH640M2QA","article-title":"Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques","volume":"121","author":"Morice","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"214","key":"10.1016\/j.path.2019.03.006_bib37","doi-asserted-by":"crossref","first-page":"214ra171","DOI":"10.1126\/scitranslmed.3007420","article-title":"Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma","volume":"5","author":"Weng","year":"2013","journal-title":"Sci Transl Med"},{"issue":"440","key":"10.1016\/j.path.2019.03.006_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5894","article-title":"High-throughput sequencing of the T cell receptor beta\u00a0gene identifies aggressive early-stage mycosis fungoides","volume":"10","author":"de Masson","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib40","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by\u00a0cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1309\/NNV4L5G5A0KF1T06","article-title":"CD8+ lymphomatoid papulosis and its differential diagnosis","volume":"125","author":"Magro","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.path.2019.03.006_bib42","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A\u00a0variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2019.03.006_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cup.12871","article-title":"Follicular lymphomatoid papulosis with follicular mucinosis: a clinicopathologic study of 3 cases with literature review and conceptual reappraisal","volume":"44","author":"Dore","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib47","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK\u2212 anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.leukres.2012.12.001","article-title":"The significance of MUM1\/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: a study of 53 cases","volume":"37","author":"Kiran","year":"2013","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib53","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib54","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/bjd.13690","article-title":"Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases","volume":"172","author":"Fauconneau","year":"2015","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib55","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000000217","article-title":"Intralymphatic cutaneous anaplastic large cell lymphoma\/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders","volume":"38","author":"Samols","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1016\/j.path.2019.03.006_bib56","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2019.03.006_bib57","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAS.0000000000001174","article-title":"An immune suppression-associated EBV-positive anaplastic large cell lymphoma with a BRAF V600E mutation","volume":"43","author":"Gru","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ijd.13804","article-title":"ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature","volume":"57","author":"Geller","year":"2018","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.path.2019.03.006_bib60","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/ijd.14156","article-title":"Comments concerning \"ALK positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature\"","volume":"57","author":"Bhattacharjee","year":"2018","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.path.2019.03.006_bib62","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2019.03.006_bib63","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.hoc.2018.08.004","article-title":"Rare cutaneous T-cell lymphomas","volume":"33","author":"Damasco","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/his.13671","article-title":"T-cell receptor-\u03b4 expression and \u03b3\u03b4+ T-cell infiltrates in primary cutaneous \u03b3\u03b4 T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders","volume":"73","author":"Pulitzer","year":"2018","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2019.03.006_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/DAD.0000000000000493","article-title":"Phenotypic variation in different lesions of mycosis fungoides biopsied within a short period of time from the same patient","volume":"38","author":"Kash","year":"2016","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary cutaneous T-cell lymphomas showing gamma-delta (\u03b3\u03b4) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib68","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2340\/00015555-1145","article-title":"Lymphomatoid papulosis showing \u03b3\u03b4 T-cell phenotype","volume":"91","author":"Morimura","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-gamma expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodriguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2019.03.006_bib70","first-page":"5873015","article-title":"\u03b3\u03b4 T-cell acute lymphoblastic leukemia\/lymphoma: discussion of two pediatric cases and its distinction from other mature \u03b3\u03b4 T-cell malignancies","volume":"2017","author":"Wei","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/cup.12601","article-title":"Atypical cutaneous \u03b3\u03b4 T cell proliferation with morphologic features of lymphoma but with clinical features and course of PLEVA or lymphomatoid papulosis","volume":"42","author":"King","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2019.03.006_bib72","unstructured":"Gru A, et\u00a0al, in press."},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib73","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib74","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cup.12633","article-title":"Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient","volume":"43","author":"Kluk","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.03.006_bib76","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cup.13020","article-title":"Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: a long-standing case with an unexpected progression","volume":"44","author":"Alberti-Violetti","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib77","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/DAD.0000000000001017","article-title":"Primary cutaneous CD8+ T-cell lymphoma, an indolent and locally aggressive form mimicking paronychia","volume":"40","author":"Beggs","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12788\/j.sder.2018.006","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Gru","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib81","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/DAD.0000000000000597","article-title":"Differential NFATc1 expression in primary cutaneous CD4+ small\/medium-sized pleomorphic t-cell lymphoma and other forms of cutaneous T-cell lymphoma and pseudolymphoma","volume":"39","author":"Magro","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"20","key":"10.1016\/j.path.2019.03.006_bib83","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.006_bib84","first-page":"123","article-title":"Primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review","volume":"17","author":"Salah","year":"2019","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/j.path.2019.03.006_bib85","first-page":"389","article-title":"Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category","volume":"12","author":"Williams","year":"2011","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.path.2019.03.006_bib86","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2019.03.006_bib87","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/cup.12801","article-title":"Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation","volume":"43","author":"Chen","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib88","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":"The association of latent Epstein-Barr virus infection with hydroa vacciniforme","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.path.2019.03.006_bib89","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90181-7","article-title":"Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential","volume":"32","author":"Ruiz-Maldonado","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.path.2019.03.006_bib91","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2133.1996.99812.x","article-title":"An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face","volume":"134","author":"Cho","year":"1996","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.path.2019.03.006_bib92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.13411","article-title":"Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites","volume":"172","author":"Miyake","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.path.2019.03.006_bib93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2016.04.010","article-title":"Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology","volume":"82","author":"Tatsuno","year":"2016","journal-title":"J\u00a0Dermatol Sci"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:27Z","timestamp":1761748767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300236"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.006","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in Cutaneous T-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}